To Immunity and Beyond
To Immunity and Beyond
Podcast Description
In a series produced by the Oxford Immunology Network, Professor Paul Klenerman talks with colleagues about their recent ground-breaking publications, exploring the original scientific goals, challenges they encountered along the way, and future ambitions in the field. This series will be of interest to anyone studying or working in immunology, medical sciences, biology or related fields.
NB: To Immunity and Beyond is for educational purposes only and should not be considered professional medical advice.
Podcast Insights
Content Themes
The series centers on pivotal themes in immunology, medical sciences, and biology, exploring current research advancements. Specific episode examples include discussions on CAR-T cell sensitivity engineering, the role of ADAM10 in T cell efferocytosis, and genetic risks for multiple sclerosis in historical populations, presenting foundational studies and their implications for future research.

In a series produced by the Oxford Immunology Network, Professor Paul Klenerman talks with colleagues about their recent ground-breaking publications, exploring the original scientific goals, challenges they encountered along the way, and future ambitions in the field. This series will be of interest to anyone studying or working in immunology, medical sciences, biology or related fields.
NB: To Immunity and Beyond is for educational purposes only and should not be considered professional medical advice.
A conversation with Professor Hashem Koohy about possibilities for use of AI in driving forward T cell research. In the first To Immunity and Beyond episode of 2026, Paul Klenerman speaks with systems biologist Hashem Koohy, whose career journey from pure mathematics to immunology offers a fresh lens on T cell research. Hashem describes how advances in genomics, data science, and AI led him to focus on one of immunology’s central challenges: understanding how T cells recognise their targets, a process critical to infections, cancer, and immunotherapy.
The discussion explores why predicting T cell–antigen interactions remains difficult despite vast datasets and powerful AI tools. Hashem argues that progress requires more than better predictions—it demands clearer biological concepts, realistic expectations, and data designed to answer the right questions. He highlights the importance of cross-disciplinary collaboration and calls for AI to be used not just to generate results, but to reveal the underlying rules of immune recognition.
Further reading: T Cell Recognition Community LinkedIn page: https://www.linkedin.com/groups/15319051/
Hudson, D., Fernandes, R.A., Basham, M. et al. Can we predict T cell specificity with digital biology and machine learning? Nat Rev Immunol 23, 511–521 (2023). https://doi.org/10.1038/s41577-023-00835-3
McMaster, B., Thorpe, C., Ogg, G. et al. Can AlphaFold’s breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity? Nat Methods 21, 766–776 (2024). https://doi.org/10.1038/s41592-024-02240-7 Hashem’s website: https://www.immunointelligence.co.uk/ ImmSilico: https://www.immsilico.com/

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.